Northrop Grumman (NOC) Stock Dips 1.6% Despite Strong Q1 Earnings Performance

Table of Contents Northrop Grumman delivered impressive first-quarter 2026 results that exceeded analyst expectations across key metrics, yet the defense contractor’s shares retreated during Tuesday’s early market session. $NOC Q1’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $9.88B (Est. $9.76B) 🟢; +4% YoY🔹 EPS: $6.14 (Est. $6.05) 🟢🔹 Organic Sales Growth: +5%🔹 Backlog: $95.6B🔹 Net Awards: $9.8B FY Guide:🔹 Revenue: $43.5B-$44.0B (Est. $43.9B) 🟡🔹 MTM-Adjusted EPS: $27.40-$27.90 (Est.… pic.twitter.com/2mJEP9iIHa — Wall St Engine (@wallstengine) April 21, 2026 The company reported earnings per share of $6.14, comfortably above the Street’s $6.05 consensus target. Quarterly sales reached $9.88 billion, reflecting a 4% increase compared to the $9.47 billion recorded in the same period last year, and beating the anticipated $9.76 billion mark. The Aeronautics Systems division emerged as the standout performer, with revenue soaring 17%. This substantial growth stemmed from a recently secured agreement with the U.S. Air Force that accelerates B-21 bomber manufacturing capacity alongside expedited deployment of the Sentinel intercontinental ballistic missile program’s initial operational capability. Northrop Grumman Corporation, NOC Operating profit experienced a remarkable 73% surge to $989 million during the quarter. The company’s operating margin expanded significantly to 10.0% from the prior year’s 6.1%. This dramatic improvement was primarily attributed to the elimination of a $477 million charge related to the B-21 program that had negatively impacted first-quarter 2025 financial performance. Segment operating profit climbed 89% to $1.07 billion, while segment operating margins improved substantially from 6.0% to 10.8%. The defense contractor secured $9.8 billion in net new contract awards throughout the quarter. The company’s total backlog now stands at an impressive $95.6 billion — representing more than double its annual revenue. Organic revenue growth registered at 5% on a year-over-year basis. Northrop maintained its previously issued 2026 full-year guidance without modification. Management continues to anticipate total sales between $43.5 billion and $44.0 billion, with MTM-adjusted earnings per share projected in the $27.40 to $27.90 range. Current analyst consensus sits at approximately $28 for EPS — positioned above the company’s upper guidance threshold. Notably, when the defense contractor initially provided guidance in January, Wall Street expectations were hovering around $29. The company reaffirmed its free cash flow target of $3.1 billion to $3.5 billion for the year. Segment operating income guidance remains between $4.85 billion and $5.0 billion. Chief Executive Kathy Warden characterized the quarterly performance as evidence of the organization’s capability to execute amid “today’s unprecedented global demand environment.” Notwithstanding the earnings beat, NOC shares declined roughly 1.6% during premarket activity to $646.67. Meanwhile, both S&P 500 and Dow Jones Industrial Average futures were trading higher during the same timeframe. The stock had already appreciated 15% year-to-date prior to Tuesday’s announcement, and approximately 24% over the trailing twelve-month period. Shares currently command a forward price-to-earnings multiple of about 23 times, elevated from roughly 19 times one year earlier. This premium valuation level may help explain why a solid quarterly earnings performance failed to generate positive momentum for the stock, particularly given the company’s decision to maintain rather than raise its full-year outlook.